Can hematopoietic stem cell transplants prevent worsening of symptoms in multiple sclerosis?

A group of researchers based at the University of Genoa (Italy) has identified that hematopoietic stem cell transplants in individuals with multiple sclerosis (MS) can reduce the likelihood that their symptoms worsen in the long-term. The authors of the study, published in Neurology, suggest that hematopoietic stem cell transplants should be considered as a routine treatment for individuals with MS who do not respond to existing therapies. “So far, conventional treatments have prevented people with MS from experiencing more attacks and worsening symptoms, but not in the long term,” explained study author Matilde Inglese (University of Genoa). “Previous research shows...